Evidence map›Paper›PMID 26331843›Full record

Trial reportObesity (Silver Spring, Md.)2015

Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation.

Liselotte van Bloemendaal, Dick J Veltman, Jennifer S ten Kulve, Madeleine L Drent, Frederik Barkhof, Michaela Diamant, Richard G IJzerman

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Obesity (Silver Spring, Md.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03361098 (Combined Effects of SGLT2 Inhibition and GLP-1 Receptor Agonism on Food Intake, Body Weight and Central Satiety and Reward Circuits in Obese T2DM Patients), which is not on this map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03361098 phase4completedstarted 2017, after this paper: background citation

Combined Effects of SGLT2 Inhibition and GLP-1 Receptor Agonism on Food Intake, Body Weight and Central Satiety and Reward Circuits in Obese T2DM Patients

Ran2017Enrolled65Registered outcomes18Posted comparisons0ConditionsObesity, Type 2 Diabetes MellitusArmsDapagliflozin 10mg, exenatide, placebo dapagliflozin, placebo exenatide
Open the trial in the graph
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Glucocorticoids, stress and eating: The mediating role of appetite-regulating hormones.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2023
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Liselotte van BloemendaalDiabetes Center/Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands.
Dick J VeltmanDepartment of Psychiatry, VU University Medical Center, Amsterdam, the Netherlands.
Jennifer S ten KulveDiabetes Center/Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands.
Madeleine L DrentDepartment of Internal Medicine/Endocrine Section/Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.
Frederik BarkhofDepartment of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands.
Michaela DiamantDiabetes Center/Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands.
Richard G IJzermanDiabetes Center/Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands.
Amsterdam UMC Location VUmc · NLAmsterdam Neuroscience · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe neural correlates and pathophysiology of emotional eating are insufficiently known. Glucagon-like peptide-1 (GLP-1), a postprandial hormone, plays a role in feeding behavior by signaling satiety to the brain. GLP-1 receptor agonists, used for treatment of type 2 diabetes (T2DM), promote weight loss. This study investigated the association between emotional eating and responses to food-cues in brain areas involved in satiety and reward processing, as well as GLP-1 receptor agonist-induced effects on these brain responses.

methodsT2DM patients with obesity, normoglycemic individuals with obesity, and lean individuals (n = 48) were studied in a randomized placebo-controlled crossover study. Using functional MRI, we determined the relation between emotional eating and regional brain responses to visual food stimuli and acute effects of intravenous administration of the GLP-1 receptor agonist exenatide on these responses.

resultsEmotional eating scores positively correlated with responses to food-cues in lean subjects in the insula, in normoglycemic subjects with obesity in the insula, and in T2DM patients in the amygdala, orbitofrontal cortex, and insula. Emotional eating scores negatively correlated with exenatide-induced reductions in responses to food-cues in normoglycemic subjects with obesity in the amygdala and in T2DM patients in the insula.

conclusionsOur findings indicate that emotional eaters have altered brain responses to food-cues and are less sensitive to the central effects of GLP-1 receptor activation.

Indexed as

BrainCross-Over StudiesEatingEmotionsFeeding BehaviorFemaleGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorHumansMaleMiddle AgedSurveys and QuestionnairesGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor

Identifiers

PMID26331843
OpenAlexW1951432620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.